Skip to main content

Table 5 Staphylococcus spp. and methicillin-resistance by country in 2012–2013

From: European multicenter study on antimicrobial resistance in bacteria isolated from companion animal urinary tract infections

  Staphylococci species by country Methicillin-resistance within each group
Countrya N SA SP CoPS CoNS SPP MRSA MRSP MRCoNS
   %
(95 % CI)b
%
(95 % CI)b
%
(95 % CI)b
%
(95 % CI)b
%
(95 % CI)b
n
tested
R %
(95 % CI)b
n
tested
R %
(95 % CI)b
n
tested
R %
(95 % CI)b
AT 78 7.69
(1.78–13.61)
19.23
(10.48–27.98)
6.41
(0.97–11.85)
56.41
(45.41–67.41)
10.26
(3.52–16.99)
5 1R/4S
-
15 33.33
(9.48–57.19)
43 27.91
(14.50–41.31)
BE 122 14.75
(8.46–21.05)
52.46
(43.60–61.32)
0
-
32.79
(24.46–41.12)
0
-
18 5.56
(0–16.14)
64 12.50
(4.40–20.60)
40 25.0
(11.58–38.42)
DK 52 1.92
(0–5.66)
53.85
(40.30–67.40)
1.92
(0–5.66)
28.85
(16.53–41.16)
13.46
(4.18–22.74)
1 1S
-
27 0
-
15 46.67
(21.42–71.91)
FR 242 8.26
(4.80–11.73)
72.73
(67.12–78.34)
0
-
19.01
(14.06–23.95)
0
-
20 40.0
(18.53–61.47)
0 -
-
46 17.39
(6.44–28.34)
DE 64 4.69
(0–9.87)
50.0
(37.75–62.25)
0
-
39.06
(27.11–51.02)
6.25
(0.32–12.18)
0 -
-
0 -
-
0 -
-
EL 10 0
-
10.0
(0–28.59)
0
-
0
-
90
(71.41–100)
- -
-
1 1R
-
- -
-
IT 19 0
-
94.74
(84.70–100)
0
-
5.26
(0–15.30)
0
-
- -
-
18 50.0
(26.90–73.10)
0 -
-
NL 365 4.93
(1.12–2.71)
47.95
(42.82–53.07)
0
-
47.12
(42.0–52.24)
0
-
0 -
-
174 10.92
(6.29–15.55)
172 0.58
(0–1.72)
PT 7 1SA
-
4SP
-
0CoPS
-
0CoNS
-
2SPP
-
1 1R
-
4 2R/2S
-
0 -
-
RS 0 -
-
-
-
-
-
-
-
-
-
- -
-
- -
-
- -
-
ES 13 0
-
0
-
15.38
(0–35.0)
46.15
(19.05–73.25)
38.46
(12.02–64.91)
- -
-
- -
-
0 -
-
SE 325 8.62
(5.56–11.67)
53.54
(48.12–58.96)
2.46
(0.78–4.15)
32.31
(27.22–37.39)
3.08
(1.20–4.95)
28 0
-
174 1.15
(0–2.73)
105 4.76
(0.69–8.84)
CH 46 4.35
(0–10.24)
52.17
(37.74–66.61)
4.35
(0–10.24)
34.78
(21.02–48.55)
4.35
(0–10.24)
2 0R/2S
-
20 10.00
(0–23.15)
15 66.67
(42.81–90.52)
UK 32 12.50
(1.04–23.96)
53.13
(35.84–70.41)
6.25
(0–14.64)
18.75
(5.23–32.27)
9.38
(0–19.47)
3 1R/2S
-
12 8.33
(0–23.97)
3 1R/2S
-
  1. Staphylococci identification varied according to the country. Some countries identified staphylococci to species level, others to genus level and others included data on the coagulase test. Thus, the staphylococci results were grouped as follows: 1. Staphylococcus aureus (SA); 2. Staphylococcus pseudintermedius (SP); 3. coagulase positive staphylococci (CoPS), 4. coagulase negative staphylococci (CoNS) and 5. other staphylococci (SPP). Group 2 includes staphylococci identified only as CoPS or staphylococci species known to be coagulase positive other than SA and SP. Group 3 includes staphylococci identified only as CoNS or staphylococci species known to be coagulase negative. Group 4 includes staphylococci identified as Staphylococcus spp
  2. MRSA methicillin-resistant Staphylococcus aureus, MRSP methicillin-resistant Staphylococcus pseudintermedius, MRCoNS methicillin-resistant coagulase negative staphylococci
  3. aCountries: AT, Austria; BE, Belgium; DK, Denmark; FR, France; DE, Germany; EL, Greece; IT, Italy; NL, the Netherlands; PT, Portugal; RS, Serbia; ES, Spain; SE, Sweden; CH, Switzerland; UK, United Kingdom
  4. b95 % CI, 95 % Confidence interval
  5. N, Total number of staphylococci
  6. n tested, number of staphylococci tested for methicillin-resistance within each group